Nanoscaled aptasensors for multi-analyte sensing.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 4298712)

Published in Bioimpacts on November 22, 2014

Authors

Mehdi Saberian-Borujeni1, Mohammad Johari-Ahar1, Hossein Hamzeiy1, Jaleh Barar1, Yadollah Omidi1

Author Affiliations

1: Research Center for Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.

Articles cited by this

In vitro selection of RNA molecules that bind specific ligands. Nature (1990) 30.19

Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature (1992) 3.02

Analysis of exocytotic events recorded by amperometry. Nat Methods (2005) 2.35

Immobilization of nucleic acids at solid surfaces: effect of oligonucleotide length on layer assembly. Biophys J (2000) 2.34

Aptamer beacons for the direct detection of proteins. Anal Biochem (2001) 2.12

Cell-specific internalization study of an aptamer from whole cell selection. Chemistry (2008) 1.81

A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism. Cancer Res (2010) 1.72

Electrochemical biosensors: recommended definitions and classification. Biosens Bioelectron (2001) 1.66

Automated selection of anti-protein aptamers. Bioorg Med Chem (2001) 1.60

Aptamers: molecular tools for analytical applications. Anal Bioanal Chem (2007) 1.60

Detection of protein biomarkers using RNA aptamer microarrays and enzymatically amplified surface plasmon resonance imaging. Anal Chem (2007) 1.56

First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers. Circulation (2007) 1.51

Molecular aptamer beacons for real-time protein recognition. Biochem Biophys Res Commun (2002) 1.49

Spatially addressable multiprotein nanoarrays templated by aptamer-tagged DNA nanoarchitectures. J Am Chem Soc (2007) 1.49

Aptamer-based sensor arrays for the detection and quantitation of proteins. Anal Chem (2004) 1.37

A simple and sensitive "dipstick" test in serum based on lateral flow separation of aptamer-linked nanostructures. Angew Chem Int Ed Engl (2006) 1.37

Selection of fluorescent aptamer beacons that light up in the presence of zinc. Anal Bioanal Chem (2007) 1.37

Aptamer-based biosensor arrays for detection and quantification of biological macromolecules. Anal Biochem (2003) 1.37

Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy. Mol Ther Nucleic Acids (2014) 1.32

Modern potentiometry. Angew Chem Int Ed Engl (2007) 1.24

Quantum-dot/aptamer-based ultrasensitive multi-analyte electrochemical biosensor. J Am Chem Soc (2006) 1.20

Simultaneous detection of diverse analytes with an aptazyme ligase array. Anal Biochem (2003) 1.15

Optimization of aptamer microarray technology for multiple protein targets. Anal Chim Acta (2006) 1.14

Aptasensors--the future of biosensing? Anal Bioanal Chem (2001) 1.13

Quantum-dot aptamer beacons for the detection of proteins. Chembiochem (2005) 1.10

Influence of ionic strength, pH and aptamer configuration for binding affinity to thrombin. Bioelectrochemistry (2006) 1.08

In vitro selection of DNA aptamer against abrin toxin and aptamer-based abrin direct detection. Biosens Bioelectron (2006) 1.03

Affinity analysis of a protein-aptamer complex using nonequilibrium capillary electrophoresis of equilibrium mixtures. Anal Chem (2003) 1.01

Quantum dot encoding of aptamer-linked nanostructures for one-pot simultaneous detection of multiple analytes. Anal Chem (2007) 0.99

Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models. Arthritis Rheum (2011) 0.98

Nanoscale potentiometry. Trends Analyt Chem (2008) 0.97

Easy-to-use dipstick tests for detection of lead in paints using non-cross-linked gold nanoparticle-DNAzyme conjugates. Chem Commun (Camb) (2010) 0.95

Selection of RNA aptamers to the Alzheimer's disease amyloid peptide. Biochem Biophys Res Commun (2002) 0.95

Aptamers as molecular recognition elements for electrical nanobiosensors. Anal Bioanal Chem (2007) 0.94

Label-free and reagent-less protein biosensing using aptamer-modified extended-gate field-effect transistors. Biosens Bioelectron (2013) 0.93

Measuring metabolism and biophysical flux in the tissue, cellular and sub-cellular domains: recent developments in self-referencing amperometry for physiological sensing. Biosens Bioelectron (2006) 0.92

Multiplexed detection of tumor markers with multicolor quantum dots based on fluorescence polarization immunoassay. Talanta (2012) 0.88

Multifunctional label-free electrochemical biosensor based on an integrated aptamer. Anal Chem (2008) 0.88

Impacts of quantum dots in molecular detection and bioimaging of cancer. Bioimpacts (2014) 0.87

Translational Approaches towards Cancer Gene Therapy: Hurdles and Hopes. Bioimpacts (2012) 0.87

A SPR aptasensor for detection of avian influenza virus H5N1. Sensors (Basel) (2012) 0.86

Micropatterning of Aptamer Beacons to Create Cytokine-Sensing Surfaces. Cell Mol Bioeng (2010) 0.86

Aptamer-targeted DNA nanostructures for therapeutic delivery. Mol Pharm (2014) 0.85

Aptamers: from bench side research towards patented molecules with therapeutic applications. Expert Opin Ther Pat (2009) 0.85

Selection of a DNA aptamer against norovirus capsid protein VP1. FEMS Microbiol Lett (2014) 0.84

Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy. ChemMedChem (2014) 0.84

Label-free solution-based kinetic study of aptamer-small molecule interactions by kinetic capillary electrophoresis with UV detection revealing how kinetics control equilibrium. Anal Chem (2011) 0.84

Characterization and application of a DNA aptamer binding to L-tryptophan. Analyst (2010) 0.82

Tunable aptamer capillary electrophoresis and its application to protein analysis. J Am Chem Soc (2007) 0.82

Development of a dual-aptamer-based multiplex protein biosensor. Biosens Bioelectron (2010) 0.82

Aptamers as inhibitors of target proteins. Expert Opin Ther Pat (2009) 0.82

An aptamer-based biosensor for mammalian initiation factor eukaryotic initiation factor 4A. Anal Biochem (2009) 0.82

Purification of a highly modified RNA-aptamer. Effect of complete denaturation during chromatography on product recovery and specific activity. J Chromatogr B Biomed Sci Appl (1999) 0.81

Conducting polymer-based impedimetric aptamer biosensor for in situ detection. Anal Bioanal Chem (2008) 0.81

Aptamer beacons for visualization of endogenous protein HIV-1 reverse transcriptase in living cells. Biosens Bioelectron (2011) 0.81

Aptamer-modified monolithic capillary chromatography for protein separation and detection. Anal Chem (2008) 0.81

Multi-analyte homogenous immunoassay based on quenching of quantum dots by functionalized graphene. Anal Bioanal Chem (2014) 0.81

In vitro selection of DNA aptamers which bind to cholic acid. Biochim Biophys Acta (2000) 0.81

Parallel analysis of two analytes in solutions or on surfaces by using a bifunctional aptamer: applications for biosensing and logic gate operations. Chembiochem (2008) 0.80

Fast and accurate analysis of drugs using amperometry associated with flow injection analysis. J Pharm Sci (2010) 0.80

Development of aptamer beacons for rapid presumptive detection of Bacillus spores. J Fluoresc (2012) 0.79

Aptasensors: a review. J Biomed Nanotechnol (2010) 0.79

Multi-targeting single fiber-optic biosensor based on evanescent wave and quantum dots. Biosens Bioelectron (2010) 0.79

Chemiluminescence detection of protein in capillary electrophoresis using aptamer-functionalized gold nanoparticles as biosensing platform. J Chromatogr A (2014) 0.78

Development of RNA aptamer-based therapeutic agents. Curr Med Chem (2013) 0.78

Highly sensitive determination of recombinant human erythropoietin-alpha in aptamer-based affinity probe capillary electrophoresis with laser-induced fluorescence detection. J Chromatogr A (2010) 0.78

Aptamer affinity chromatography for rapid assay of adenosine in microdialysis samples collected in vivo. J Chromatogr A (2003) 0.78

Aptamer-based label-free method for hemin recognition and DNA assay by capillary electrophoresis with chemiluminescence detection. Anal Bioanal Chem (2007) 0.78

High performance aptamer affinity chromatography for single-step selective extraction and screening of basic protein lysozyme. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.78

Multianalyte electrochemical biosensor based on aptamer- and nanoparticle-integrated bio-barcode amplification. Chem Asian J (2010) 0.78

Aptamer-conjugated theranostic hybrid graphene oxide with highly selective biosensing and combined therapy capability. Faraday Discuss (2014) 0.77

Ultra-fast liquid chromatography with tandem mass spectrometry determination of ochratoxin A in traditional Chinese medicines based on vortex-assisted solid-liquid microextraction and aptamer-affinity column clean-up. J Sep Sci (2014) 0.77

Aptamer/quantum dot-based simultaneous electrochemical detection of multiple small molecules. Anal Chim Acta (2010) 0.77

A universal amplified strategy for aptasensors: enhancing sensitivity through allostery-triggered enzymatic recycling amplification. Biosens Bioelectron (2012) 0.76

Exocytosis: using amperometry to study presynaptic mechanisms of neurotoxicity. Neurotoxicology (2004) 0.76

A non-labeled DNA biosensor based on light addressable potentiometric sensor modified with TiO2 thin film. J Zhejiang Univ Sci B (2009) 0.76

Disposable surface plasmon resonance aptasensor with membrane-based sample handling design for quantitative interferon-gamma detection. Lab Chip (2014) 0.76

High-throughput bead-based identification of structure-switching aptamer beacons. Chembiochem (2014) 0.76

Competitive affinity capillary electrophoresis assay based on a "hybrid" pre-incubation/on-capillary mixing format using an enantioselective aptamer as affinity ligand. J Sep Sci (2008) 0.76

Aptamer-modified micellar electrokinetic chromatography for the enantioseparation of nucleotides. Anal Chem (2009) 0.76

Immobilization of aptamer-based molecular beacons onto optically-encoded micro-sized beads. J Nanosci Nanotechnol (2011) 0.76

Development of naturally selected and molecularly engineered intrachain and competitive FRET-aptamers and aptamer beacons. Comb Chem High Throughput Screen (2011) 0.76

Development of a label-free aptasensor for monitoring the self-association of lysozyme. Analyst (2013) 0.76

Characterization of a modified gold platform for the development of a label-free anti-thrombin aptasensor. Biosens Bioelectron (2012) 0.75

Articles by these authors

Dysregulated pH in Tumor Microenvironment Checkmates Cancer Therapy. Bioimpacts (2013) 1.11

Kinetic studies of bovine serum albumin interaction with PG and TBHQ using surface plasmon resonance. Int J Biol Macromol (2016) 0.99

Ocular Drug Delivery; Impact of in vitro Cell Culture Models. J Ophthalmic Vis Res (2009) 0.96

Intrinsic bio-signature of gene delivery nanocarriers may impair gene therapy goals. Bioimpacts (2013) 0.87

Impacts of quantum dots in molecular detection and bioimaging of cancer. Bioimpacts (2014) 0.87

Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines. Bioimpacts (2014) 0.86

Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer. Bioimpacts (2014) 0.85

Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients. Bioimpacts (2015) 0.85

Integration of Molecular, Cellular and Translational Researches in BioImpacts. Bioimpacts (2011) 0.81

An update to DNA ladder assay for apoptosis detection. Bioimpacts (2015) 0.80

Computerized techniques pave the way for drug-drug interaction prediction and interpretation. Bioimpacts (2016) 0.79

A prospective highlight on exosomal nanoshuttles and cancer immunotherapy and vaccination. Bioimpacts (2015) 0.78

Phytochemistry and biologic activities of caulerpa peltata native to oman sea. Iran J Pharm Res (2014) 0.77

Hydrogels for ocular drug delivery and tissue engineering. Bioimpacts (2015) 0.76

Personalized cell-mediated immunotherapy and vaccination: combating detrimental uprisings of malignancies. Bioimpacts (2015) 0.75

Bioimpacts of nanoparticle size: why it matters? Bioimpacts (2015) 0.75